The overall aim of IMODI is to accelerate therapeutic innovation and identification of anticancer therapies, with a rapid transfer to the clinic, to the direct benefit of patients.
Total Budget: 41 Million Euros.French government support: 13.4 Million Euros
Duration of Project: 7 years
CTI BIOTECH has helped to create and start one of Europe’s largest company-hospital-university networks, part funded with French government money and part-financed by the companies involved.
4 Large international Pharmaceutical corporationsIPSEN www.ipsen.com
Pierre Fabre www.pierre-fabre.com
Sanofi www.sanofi.fr
Servier www.servier.fr
6 SME companies CTIBIOTECH www.ctibiotech.com
Ariana Pharma www.arianapharma.com
Module Bio www.modul-bio.com
Oncodesign www.oncodesign.com
Oncomedics www.oncomedics.com
7 academic institutions/hospitalsINSERM www.inserm.fr
CNRS www.cnrs.fr
Universite de Strasbourg http://ea3430.unistra.fr/
CHU de Toulouse www.chu-toulouse.fr
Centre Leon Berard, Lyon www.centreleonberard.fr
Synergie Lyon Cancer www.syndergielyoncancer.fr
Centre G-F Leclerc, Dijon www.cgfl.fr
The IMODI project was launched by the French President, Francois Hollande
IMODI will create platforms for next generation Cancer strategies
Notably:
- Develop innovative predictive cancer models (CTIBIOTECH and partners)
- Organize and standardise collection of fresh human cancer samples
- Creation of a biobank of Cancer biopsies, cells and models (at CTIBIOTECH)
- Model the tumor microenvironment using mouse models (with CTIBIOTECH)
- Study the role of the microbiome and gut flora in the initiation, the progression and the sensitivity to treatment in Cancer
- Create a database of information on Cancer in the IMODI project
- Datamine all information from the IMODI project and beyond to advance therapy
- Advance new drugs towards personalised medicine
The project will start with 9 main cancer areas:
Breast – Colorectal -Leukemia – Liver -Lung -Lymphoma -Myeloma – Ovarian -Pancreas -Prostate
Project IMODI comes with the significant government support of BPIFrance
MEDIA: how CTIBIOTECH works on this project was covered by the Industrie & Technologies magazine in October 2015. You can read this article (in French) here